CUMBERLAND PHARMACEUTICALS ANNUAL 13G FILING

Company

CUMBERLAND PHARMACEUTICALS INC

Filed

February 12, 2010

Accession Number

0000053417-10-000046

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →